Veselin Mitrović

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial

Iacopo Olivotto, Artur Oręziak, Roberto Barriales‐Villa et al. · The Lancet · 2020 · 1.2K citations · Full text

Medicine, Cardiology, Pharmacotherapy +6

Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial

Ferenc Folláth, H. Just, JGY Papp et al. · The Lancet · 2002 · 1.2K citations

Medicine, Cardiology, Pharmacology +12

Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure

Markku S. Nieminen, Juha Akkila, Franz X. Kleber et al. · Journal of the American College of Cardiology · 2000 · 384 citations

Pharmacy, Cardiology, Pharmacotherapy +15

Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction

Diana Bonderman, Stefano Ghio, Stephan B. Felix et al. · Circulation · 2013 · 325 citations

Medicine, Pharmacology, Pharmacotherapy +16

Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure (COSMIC-HF): a phase 2, pharmacokinetic, randomised, placebo-controlled trial

John R. Teerlink, G. Michael Felker, John J.V. McMurray et al. · The Lancet · 2016 · 293 citations · Full text

Medicine, Cardiology, Physiology +10